Cargando…

Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival

Anti-Müllerian hormone (AMH) type II receptor (AMHRII) and the AMH/AMHRII signaling pathway are potential therapeutic targets in ovarian carcinoma. Conversely, the role of the three AMH type I receptors (AMHRIs), namely activin receptor-like kinase (ALK)2, ALK3 and ALK6, in ovarian cancer remains to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chauvin, Maëva, Garambois, Véronique, Choblet, Sylvie, Colombo, Pierre-Emmanuel, Chentouf, Myriam, Gros, Laurent, De Brauwere, David-Paul, Duonor-Cerutti, Martine, Dumas, Karen, Robert, Bruno, Jarlier, Marta, Martineau, Pierre, Navarro-Teulon, Isabelle, Pépin, David, Chardès, Thierry, Pèlegrin, André
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131086/ https://www.ncbi.nlm.nih.gov/pubmed/34013359 http://dx.doi.org/10.3892/ijo.2021.5223

Ejemplares similares

Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells
por: Chauvin, Maëva, et al.
Publicado: (2021)

Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody‐dependent HER4 intracellular domain trafficking
por: Lanotte, Romain, et al.
Publicado: (2020)

Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer
por: Rabia, Emilia, et al.
Publicado: (2023)

Activin B and Activin C Have Opposing Effects on Prostate Cancer Progression and Cell Growth
por: Reader, Karen L., et al.
Publicado: (2022)

Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice
por: Ladjemi, Maha Z, et al.
Publicado: (2011)

Comparison between Internalizing Anti-HER2 mAbs and Non-Internalizing Anti-CEA mAbs in Alpha-Radioimmunotherapy of Small Volume Peritoneal Carcinomatosis Using (2) (1) (2)Pb
por: Boudousq, Vincent, et al.
Publicado: (2013)

Improving Biologics’ Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures
por: Larbouret, Christel, et al.
Publicado: (2021)

The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells
por: Estupina, Pauline, et al.
Publicado: (2017)

Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models
por: Rabia, Emilia, et al.
Publicado: (2021)

Towards international standardization of immunoassays for Müllerian inhibiting substance/anti-Müllerian hormone
por: Ferguson, Jackie MC, et al.
Publicado: (2018)

Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects
por: Paillas, Salomé, et al.
Publicado: (2016)

Peptides in Receptor-Mediated Radiotherapy: From Design to the Clinical Application in Cancers
por: Lozza, Catherine, et al.
Publicado: (2013)

A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions
por: Neiveyans, Madeline, et al.
Publicado: (2019)

Durable contraception in the female domestic cat using viral-vectored delivery of a feline anti-Müllerian hormone transgene
por: Vansandt, Lindsey M., et al.
Publicado: (2023)

Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer
por: Azria, D, et al.
Publicado: (2003)

Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6(th) antibody industrial symposium, June 25-26, 2018, Montpellier, France
por: Martineau, Pierre, et al.
Publicado: (2019)

The α1,6-Fucosyltransferase Gene (fut8) from the Sf9 Lepidopteran Insect Cell Line: Insights into fut8 Evolution
por: Juliant, Sylvie, et al.
Publicado: (2014)

Circulating Activin A predicts survival in cancer patients
por: Loumaye, Audrey, et al.
Publicado: (2017)

Neoadjuvant Treatment With Müllerian-Inhibiting Substance Synchronizes Follicles and Enhances Superovulation Yield
por: Kano, Motohiro, et al.
Publicado: (2019)

Activin eases asthma
por: Leslie, Mitch
Publicado: (2009)

Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumors
por: Kim, Jang Heub, et al.
Publicado: (2014)

Activin Biology After Lung Transplantation
por: Westall, Glen P., et al.
Publicado: (2017)

Mutational Analysis of the Putative Anti-Müllerian Hormone (AMH) Binding Interface on its Type II Receptor, AMHR2
por: Hart, Kaitlin N, et al.
Publicado: (2020)

The orphan ligand, activin C, signals through activin receptor-like kinase 7
por: Goebel, Erich J, et al.
Publicado: (2022)

Human and mouse activin genes: Divergent expression of activin A protein variants and identification of a novel heparan sulfate-binding domain in activin B
por: Billings, Paul C., et al.
Publicado: (2020)

Activin A Is Essential for Neurogenesis Following Neurodegeneration
por: Abdipranoto-Cowley, Andrea, et al.
Publicado: (2009)

Xnrs and Activin Regulate Distinct Genes during Xenopus Development: Activin Regulates Cell Division
por: Ramis, Joana M., et al.
Publicado: (2007)

An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
por: Morabito, Morgane, et al.
Publicado: (2019)

Role of Activins in Hepcidin Regulation during Malaria
por: Spottiswoode, Natasha, et al.
Publicado: (2017)

Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression
por: Cate, Richard L.
Publicado: (2022)

Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
por: Ashraf, Yahya, et al.
Publicado: (2019)

Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues
por: Schaik, R H N van, et al.
Publicado: (2000)

Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects
Publicado: (1995)

The evolution of Müllerian mimicry
por: Sherratt, Thomas N.
Publicado: (2008)

Structure and activation of pro-activin A
por: Wang, Xuelu, et al.
Publicado: (2016)

Activin, neutrophils, and inflammation: just coincidence?
por: Sideras, Paschalis, et al.
Publicado: (2013)

Diagnostic utility of PAX8 in differentiation of mullerian from non-mullerian tumors
por: Heidarpour, Mitra, et al.
Publicado: (2014)

Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice
por: Coelho, M, et al.
Publicado: (2004)

Activin promotes oocyte development in ovine preantral follicles in vitro
por: Thomas, Fiona H, et al.
Publicado: (2003)

An Activin Receptor IA/Activin-Like Kinase-2 (R206H) Mutation in Fibrodysplasia Ossificans Progressiva
por: Herrera-Esparza, Rafael, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a4oir27bc5lr6ud1t0e9kj2t92